Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Team uncovers link between hormone levels and risk for metabolic disease

The work may pave the way for new therapies for obesity and diabetes

Working with a national team of researchers, a scientist from the Florida campus of The Scripps Research Institute has shown for the first time a link between low levels of a specific hormone and increased risk of metabolic disease in humans.

The study, published online ahead of print in The Journal of Clinical Endocrinology & Metabolism, focuses on the hormone adropin, which was previously identified by Scripps Research Associate Professor Andrew Butler's laboratory during an investigation of obese and insulin-resistant mice. Adropin is believed to play an important role in regulating glucose levels and fatty acid metabolism.

"The results of this clinical study suggest that low levels of adropin may be a factor increasing risk for developing metabolic disorders associated with obesity and insulin resistance, which could then lead to diseases such as type 2 diabetes," said Butler, who led the new study with Peter J. Havel, professor of molecular biosciences and nutrition at the University of California, Davis.

Approximately 47 million adults in the United States have metabolic syndrome, according to the American College of Cardiology. The National Institutes of Health defines metabolic syndrome as a group of risk factors, especially obesity and insulin resistance, that occur together and increase the risk for coronary artery disease, stroke, and type 2 diabetes.

Intriguing Results

In the new study, which involved 85 women and 45 men, Butler and his colleagues showed that obesity is associated with lower adropin levels. Lower adropin levels were also observed in individuals with a higher "metabolic syndrome risk factor" score, a score determined by measuring triglycerides, LDL cholesterol, HDL, glucose, blood pressure, and waist circumference.

The scientists also observed circulating adropin concentrations increased significantly at three and six months following gastric bypass surgery in morbidly obese patients. Interestingly, adropin levels returned to pre-surgical levels at 12 months after surgery.

Another surprising finding of the new study was that in people of normal weight, women had lower plasma adropin levels than men. In addition, obesity had a bigger negative effect on adropin levels in men. Interestingly, obesity in woman was also not associated with lower plasma adropin levels. The significance of the differences between men and woman is unknown at the moment.

"But the link between low levels of adropin and increased metabolic risk was observed in both sexes," Butler said. "The impact is there, irrespective of gender."

Adropin levels were also found in general to decrease with age—the decline was highest in those over 30 years of age. As with obesity, the aging effect appeared to be more pronounced in men.

Findings in Humans Mirror Preclinical Work

The new study is an important extension of earlier pre-clinical studies using animal models published in the July edition of Obesity. In that study, Butler and colleagues deleted the gene encoding adropin from mice. The scientists found that, while normal in appearance, adropin-deficient mice have insulin resistance and, when fed diets with a high fat content, develop a more severe impaired glucose tolerance (IGT). These findings suggest reduced insulin production and attenuated response to insulin, which are the defining features of type 2 diabetes. Importantly, mice having only one functional copy of the gene encoding adropin also exhibited increased propensity for developing impaired glucose tolerance with obesity. These findings provided important pre-clinical evidence evidence that low levels of adropin are associated with increased risk of developing type 2 diabetes.

In other studies, Butler's laboratory observed that obese mice exhibit dramatic reductions in circulating adropin levels, and that insulin resistance was reversed after injections with a synthetic form of adropin.

"The data from these studies provide strong evidence suggesting that low levels of adropin may be an indicator of risk for insulin resistance in obesity and, consequently, an increased risk for metabolic diseases, including type 2 diabetes," Butler said. "We see a lot of similarity between animal model data and the new human data—low adropin levels in humans are associated with a host of metabolic syndrome risk factors normally associated with obesity and insulin resistance."

Taken together, these studies suggest the possibility that therapeutics designed to boost the supply of adropin might be useful in fighting obesity and metabolic disease.

In addition to Butler and Havel, authors of the study, "Low Circulating Adropin Concentrations With Obesity And Aging Correlate With Risk Factors For Metabolic Disease And Increase After Gastric Bypass Surgery In Humans," include Charmaine S. Tam and Eric Ravussin of Louisiana State University, Baton Rouge; Kimber L. Stanhope and Mohamed R. Ali of the University of California, Davis; Bruce M. Wolfe of the Oregon Health Sciences University, Portland; and Majella O'Keeffe and Marie-Pierre St Onge of Columbia University.

The study was supported by the National Institutes of Health (award numbers HL061352, DK060412, HL075675, HL09133, UL1 RR024156-03, UL1 RR024146, and 1P30 DK072476-06); the American Diabetes Association; The Novo Nordisk Diabetes Innovation Award Program; the University of California, Davis Health Care Systems Award; the Irving Center for Translational Science; and the Pennington Biomedical Research Center's Nutrition Obesity Research Center program.

Eric Sauter | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Biologists unravel another mystery of what makes DNA go 'loopy'
16.03.2018 | Emory Health Sciences

nachricht Scientists map the portal to the cell's nucleus
16.03.2018 | Rockefeller University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>